/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Edwards Lifesciences Corp.

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$83.98 -0.0086(-0.86%) EW at 04 Dec 2025 04:31 PM Medical Devices
Lowest Today 83.94
Highest Today 85
Today’s Open 84.73
Prev. Close 84.71
52 Week High 87.40
52 Week Low 65.94
Day’s Range: Low 83.94 High 85
52-Week Range: Low 65.94 High 87.40
1 day return -
1 Week return -3.16
1 month return -0.23
3 month return +3.71
6 month return +7.8
1 year return +13.18
3 year return +13.7
5 year return -2.12
10 year return -

Institutional Holdings

Vanguard Group Inc 11.92

BlackRock Inc 9.48

JPMorgan Chase & Co 4.56

State Street Corp 4.37

Wellington Management Company LLP 3.38

Vanguard Total Stock Mkt Idx Inv 3.14

Bank of New York Mellon Corp 3.00

Vanguard 500 Index Investor 2.47

Vanguard Mid Cap Index Institutional 2.23

Citadel Advisors Llc 2.17

Geode Capital Management, LLC 2.17

Jennison Associates LLC 1.99

Vanguard Health Care Inv 1.91

DZ BANK AG Deutsche Zentral-Genossenschaftsbank Frankfurt am Main 1.56

Morgan Stanley - Brokerage Accounts 1.28

Fidelity 500 Index 1.27

NORGES BANK 1.26

Brown Advisory Holdings Inc 1.25

SPDR® S&P 500® ETF 1.21

iShares Core S&P 500 ETF 1.20

Ninety One UK Limited 1.18

Marshall Wace Asset Management Ltd 1.17

Millennium Management LLC 1.14

Northern Trust Corp 1.04

Deutsche Bank AG 1.02

Vanguard Value Index Inv 0.89

JPMorgan US Equity L 0.85

Vanguard Mid-Cap Growth ETF 0.83

Wellcome Trust Ltd 0.82

Holocene Advisors, LP 0.80

The Health Care Select Sector SPDR® ETF 0.68

Vanguard Institutional Index I 0.60

BGF World Healthscience A2 0.59

Harbor Capital Appreciation Instl 0.56

State St S&P 500® Indx SL Cl III 0.53

UniGlobal Vorsorge 0.46

Ninety One Global Franchise 0.44

Ninety One GSF Glb Frchs I Acc USD 0.44

iShares US Medical Devices ETF 0.43

Fidelity Select Medical Tech and Devcs 0.43

Market Status

Strong Buy: 10

Buy: 4

Hold: 17

Sell: 0

Strong Sell: 1

Fundamentals

Market Cap 49733.24 M

PB Ratio 4.8488

PE Ratio 37.1535

Enterprise Value 46340.48 M

Total Assets 13055.30 M

Volume 2271443

Company Financials

Annual Revenue FY23:5819000000 5819.0M, FY22:5382400000 5382.4M, FY21:5232500000 5232.5M, FY20:4386300000 4386.3M, FY19:4348000000 4348.0M

Annual Profit FY23:4538200000 4538.2M, FY22:4302000000 4302.0M, FY21:3983600000 3983.6M, FY20:3305700000 3305.7M, FY19:3233600000 3233.6M

Annual Net worth FY23:1430900000 1430.9M, FY22:1521900000 1521.9M, FY21:1503100000 1503.1M, FY20:823400000 823.4M, FY19:1046900000 1046.9M

Quarterly Revenue Q3/2025:1553100000 1553.1M, Q2/2025:1532200000 1532.2M, Q1/2025:1412700000 1412.7M, Q3/2024:1354400000 1354.4M, Q2/2024:1385900000 1385.9M

Quarterly Profit Q3/2025:1209600000 1209.6M, Q2/2025:1189600000 1189.6M, Q1/2025:1111100000 1111.1M, Q3/2024:1091500000 1091.5M, Q2/2024:1088100000 1088.1M

Quarterly Net worth Q3/2025:291100000 291.1M, Q2/2025:329800000 329.8M, Q1/2025:358000000 358.0M, Q3/2024:3070800000 3070.8M, Q2/2024:366300000 366.3M

Fund house & investment objective

Company Information Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Organisation Medical Devices

Employees 15800

Industry Medical Devices

CEO Mr. Bernard J. Zovighian

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow